Sign in
Companies / JNJ vs LLY

JNJ vs LLY: Johnson & Johnson and Eli Lilly

Pharmaceuticals
Compare more companies

Johnson & Johnson (JNJ) reported $94.2B in revenue against a 28.5% net margin, while Eli Lilly (LLY) reported $65.2B at a 31.7% net margin, most recently.

MetricJNJLLY
Revenue$94.2B$65.2B
Net Income$26.8B$20.6B
Gross Margin67.9%83.0%
Operating Margin——
EPS (Diluted)$11.03$22.95
Free Cash Flow$19.7B—
Total Debt$49.9B$42.5B
P/E Ratio18.8×46.9×
P/B Ration/mn/m
Stock Price$272.48$1375.19
Free: last 5 years
Fiscal yearFY2007 🔒FY2008 🔒FY2010 🔒FY2011 🔒FY2012 🔒FY2013 🔒FY2014 🔒FY2016 🔒FY2017 🔒FY2018 🔒FY2019 🔒FY2021FY2022FY2023FY2024FY2025
JNJ Revenue•••••••••••••••••••••••••••••••••••••••••••••••••••••••$82.6B$78.7B$85.2B$88.8B$94.2B
LLY Revenue•••••••••••••••••••••••••••••••••••••••••••••••••••••••$28.3B$28.5B$34.1B$45.0B$65.2B

More on JNJ

More on LLY

Other comparisons